Open AccessBovine Lactoferrin Prevents Invasive Fungal Infections in Very Low Birth Weight Infants: A Randomized Controlled Trial
Author(s) -
Paolo Manzoni,
Ilaria Stolfi,
Hubert Messner,
Silvia Cattani,
Nicola Laforgia,
Mario Romeo,
Lina Bollani,
Matteo Rinaldi,
Elena Gallo,
Michele Quercia,
Milena Maule,
Michael Mostert,
Lidia Decembrino,
Rosario Magaldi,
Fabio Mosca,
Federica Vagnarelli,
Luigi Memo,
Pasqua Betta,
Mauro Stronati,
Daniele Farina,
on behalf of the Italian Task Force for the Study and Prevention of Neonatal Fungal Infections–the Italian Society of Neonatology
Publication year - 2011
Publication title -
pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.611
H-Index - 345
eISSN - 1098-4275
pISSN - 0031-4005
DOI - 10.1542/peds.2011-0279
Subject(s) - medicine , lactobacillus rhamnosus , lactoferrin , placebo , randomized controlled trial , colonization , sepsis , incidence (geometry) , gastroenterology , low birth weight , birth weight , immunology , lactobacillus , microbiology and biotechnology , pregnancy , biology , optics , physics , genetics , pathology , alternative medicine , bacteria
Lactoferrin is a mammalian milk glycoprotein involved in innate immunity. Recent data show that bovine lactoferrin (bLF) prevents late-onset sepsis in preterm very low birth weight (VLBW) neonates.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom